1'-Hydroxysafrole, a Proximate Carcinogenic Metabolite of Safrole in the Rat and Mouse

Cancer Research

Volumn 33, Issue 3, 1973, Pages 590-600

  Shires, Thomas K ^b   Miller, James A ^a   Miller, Elizabeth C ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIOXOLANE DERIVATIVE; ALLYL COMPOUND; CARCINOGEN;

ACETYLATION; ANGIOSARCOMA; ANIMAL; ARTICLE; CHEMISTRY; EXPERIMENTAL NEOPLASM; FEMALE; HYDROXYLATION; IATROGENIC DISEASE; LIVER CELL CARCINOMA; LIVER TUMOR; LYMPHOMA; MALE; METABOLISM; METHYLATION; MOUSE; ORAL DRUG ADMINISTRATION; PAPILLOMA; RAT; SARCOMA; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; STOMACH TUMOR; SUBCUTANEOUS DRUG ADMINISTRATION;

ACETYLATION; ADMINISTRATION, ORAL; ALLYL COMPOUNDS; ANIMAL; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; CARCINOMA, SQUAMOUS CELL; CHEMISTRY; DIOXOLES; FEMALE; HEMANGIOSARCOMA; HYDROXYLATION; INJECTIONS, SUBCUTANEOUS; LIVER NEOPLASMS; LYMPHOMA; MALE; METHYLATION; MICE; NEOPLASMS, EXPERIMENTAL; PAPILLOMA; RATS; SARCOMA; SKIN NEOPLASMS; STOMACH NEOPLASMS;

EID: 0015591485     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. r-Acetoxy-2-fluorenylacetamide. Proc. Am. Assoc. Cancer Res., 13: 52, 1972.
2. Borchert, P., Wislocki, P. G., Miller, J. A., and Miller, E. C. The Metabolism of the Naturally Occurring Hepatocarcinogen Safrole to 1'safrole and the Electrophilic Reactivity of l'-Acetoxysafrole. Cancer Res., 33: 575-589, 1973.
3. Bresch, H., Kreibich, G., Kubinyi, H., Schairer, H. U., Thielmann, H. W., and Hecker, E. Uber die Wirkstoffe des Contronols, IX. Partialsynthese von Wirkstoffen des Crotonols. Z. Naturforsch., 23b: 538–546, 1968.
4. Culvenor, C. C. J., Downing, D. T., Edgar, J. A., and Jago, M. V. Pyrrolizidine Alkaloids as Alkylating and Antimitotic Agents. Ann. N. Y. Acad. Sci., 163: 837–847, 1969.
5. DeBaun, J. R., Miller, E. C., and Miller, J. A. N-Hydroxy-2-acetylaminofluorene Sulfotransferase: Its Probable Role in Carcinogenesis and Protein-(methion-S-yl) Binding in Rat Liver. Cancer Res., 30: 577–595, 1970.
6. DeBaun, J. R., Smith, J. Y. R., Miller, E. C., and Miller, J. A. Reactivity in vivo of the Carcinogen N-Hydroxy-2-acetylaminofluorene: Increase by Sulfate Ion. Science, 167: 184–186, 1970.
7. Dickens, F., and Jones, H. E. H. Further Studies on the Carcinogenic Action of Certain Lactones and Related Substances in the Rat and Mouse. Brit. J. Cancer, 19: 392–403, 1965.
8. Epstein, S. S., Fujii, K., Andrea, J., and Mantel, N. Carcinogenicity Testing of Selected Food Additives by Parenteral Administration to Infant Swiss Mice. Toxicol. Appl. Pharmacol., 16: 321–334, 1970.
9. Hagen, E. C., Jenner, P. M., Jones, W. I., Fitzhugh, O. G., Long, E. L., Brouwer, J. G., and Webb, W. K. Toxic Properties of Compounds Related to Safrole. Toxicol. Appl. Pharmacol., 7: 18-24, 1965.
10. Harris, P. N., Gibson, W. R., and Dillard, R. D. Pluripotent Oncogenicity of l, 1-Diphenyl-2-propynyl-N-cyclohexylcarbamate. Proc. Am. Assoc. Cancer Res., 10: 35, 1969.
11. Harris, P. N., Gibson, W. R., and Dillard, R. D. The Oncogenicity of Two 1, 1-Diaryl-2-propynWV-cy cloalkylcarbamates. Cancer Res., 30: 2952-2954, 1970.
12. Harris, P. N., Gibson, W. R., and Dillard, R. D. The Oncogenicity of Six Analogs of l, 1-Diphenyl-2-propynyl-TV-cyclohexylcarbamate. Proc. Am. Assoc. Cancer Res., 12: 26, 1971.
13. Harris, P. N., Gibson, W. R., and Dillard, R. D. Oncogenicity of l-(4-Chlorophenyl)-l-phenyl-2-propynyl Carbamate for Rats. Toxicol. Appl. Pharmacol., 21: 414–418, 1972.
14. Homburger, F., Kelley, T., Jr., Baker, T. R., and Russfield, A. B. Sex Effect on Hepatic Pathology from a Deficient Diet and Safrole in Rats. Arch. Pathol., 73: 118–125, 1962.
15. Homburger, F., Kelley, T., Jr., Friedler, G., and Russfield, A. B. Toxic and Possible Carcinogenic Effects of 4-Allyl-l, 2-methylenedioxybenzene (Safrole) in Rats on Deficient Diets. Med. Exptl., 4: 1-11, 1961.
16. Jago, M. V., Edgar, J. A., Smith, L. W., and Culvenor, C. C. J. Metabolic Conversion of Heliotridine-based Pyrrolizidine Alkaloids to Dehydroheliotridine. Mol. Pharmacol., 6: 402-406, 1970.
17. Kriek, E., Miller, J. A., Juhl, U., and Miller, E. C. 8-(N-2-Fluorenyl-acetamido)-guanosine, an Arylamidation Reaction Product of Guanosine and the Carcinogen N-Acetox y-N-2-fluorenylacetamide in Neutral Solution. Biochemistry, 6: 177–182, 1967.
18. Long, E. L., Nelson, A. A., Fitzhugh, O. G., and Hansen, W. H. Liver Tumors Produced in Rats by Feeding Safrole. Arch. Pathol., 75: 595-604, 1963.
19. Lotlikar, P. D., Scribner, J. D., Miller, J. A., and Miller, E. C. Reaction of Esters of Aromatic N-Hydroxy Amines and Amides with Methionine in vitro: A Model for in vivo Binding of Amine Carcinogens to Protein. Life Sci., 5: 1263–1269, 1966.
20. Maher, V. M., Miller, E. C., Miller, J. A., and Szybalski, W. Mutations and Decreases in Density of Transforming DNA Produced by Derivatives of the Carcinogens 2-Acetylaminofluorene and N-Methyl-4-aminoazobenzene. Mol. Pharmacol., 4: 411–426, 1968.
21. Matthews, J. S. Steroids CCXXIII. Color Reagent for Steroids in Thin-layer Chromatography. Biochim. Biophys. Acta, 69: 163–165, 1963.
22. Mattocks, A. R. Toxicity of Pyrrolizidine Alkaloids. Nature, 217: 723–728, 1968.
23. Mattocks, A. R. Synthetic Compounds with Toxic Properties Similar to Those of Pyrrolizidine Alkaloids and Their Pyrrolic Metabolites. Nature, 232: 476-477, 1971.
24. Mattocks, A. R., and White, I. N. H. The Conversion of Pyrrolizidine Alkaloids to N-Oxides and to Dehydropyrrolizine Derivatives by Rat-Liver Microsomes in Vitro. Chem.-Biol. Interactions, J: 383-396, 1971.
25. McKinney, J. D., Oswald, E., Fishbein, L., and Walker, M. On the Mechanism of Formation of of Mannich Bases as Safrole Metabolites. Bull. Environ. Contamination Toxicol., 7: 305–310, 1972.
26. Miller, J. A., and Miller, E. C. Metabolic Activation of Carcinogenic Aromatic Amines and Amides via N-Hydroxylation and N-Hydroxy-Esterification and Its Relationship to Ultimate Carcinogens as Electrophilic Reactants. In: E. D. Bergmann and B. Pullman (eds.), The Jerusalem Symposia on Quantum Chemistry and Biochemistry. Physiocochemical Mechanisms of Carcinogenesis, Vol. 1, pp. 237–261. Jerusalem: Israel Academy of Sciences and Humanities, 1969.
27. Miller, J. A., and Miller, E. C. The Metabolic Activation of Carcinogenic Aromatic Amines and Amides. Progr. Exptl. Tumor Res., 11: 273-301, 1969.
28. Oswald, E. O., Fishbein, L., Corbett, B. J., and Walker, M. P. Identification of Tertiary Aminomethylenedioxypropiophenones as Urinary Metabolites of Safrole in the Rat and Guinea Pig. Biochim. Biophys. Acta, 230: 237–247, 1971.
29. Poirier, M. M., Miller, J. A., and Miller, E. C. The Carcinogenic Activities of N-Hydroxy-2-acetylaminofluorene and Its Metal Chelates as a Function of Retention at the Injection Site. Cancer Res., 25: 527–533, 1965.
30. Van Duuren, B. L., Goldschmidt, B. M., Katz, C., and Seidman, I. Dimethylcarbamyl Chloride, a Multipotential Carcinogen. J. Natl. Cancer Inst., 48: 1539–1540, 1972.
31. Weisburger, J. H., Yamamoto, R. S., Williams, G. M., Grantham, P. H., Matsushima, T., and Weisburger, E. K. On the Sulfate Ester of N-Hydroxy-N-2-fluorenylacetamide as a Key Ultimate Hepatocarcinogen in the Rat. Cancer Res., 32: 491–500, 1972.
32. Wislocki, P. G., Borchert, P., Miller, E. C., and Miller, J. A. l'-Hydroxysafrole: A Proximate Carcinogenic Metabolite of Safrole. Proc. Am. Assoc. Cancer Res., 13: 12, 1972.